Patents by Inventor Maria Szucs

Maria Szucs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apioid analgesic without respiratory depression
    Patent number: 5457110
    Abstract: A biologically active preparation for human or veterinary use for the selective blockade of opioid binding sites of the brain responsible for respiratory depression containing in a biologically active quantity the codeinone derivative of general formula (I) or its saltR.sup.1 means amino-, hydroxyl-, --NH-phenyl or --NH--CO--NH.sub.2 groups,R.sup.2 means a hydrogen atom or a hydroxyl group.The invention also covers a process for selective blocking the opioid binding sites of the brain responsible for respiratory depression by administering to a patient in need of an analgetic a preparation containing a codeinone derivative of general formula (I) or its salt preferably three times per day in doses of 2.5-5 mg.
    Type: Grant
    Filed: May 19, 1994
    Date of Patent: October 10, 1995
    Assignee: Alkaloida Chemical Company, Ltd.
    Inventors: Anna Borsodi, Zsuzsa Furst, Sandor Hosztafi, Schafferne E. Varga, Beata Buzas, Tamas Friedmann, Sandor Benyhe, Maria Szucs
  • Pharmaceutical composition and use
    Patent number: 5317022
    Abstract: A biologically active preparation for human or veterinary use for the selective blockade of opioid binding sites of the brain responsible for respiratory depression containing in a biologically active quantity the codeinone derivative of general formula (I) or its saltR.sup.1 means amino--, hydroxyl--, --NH--phenyl or --NH--CO--NH.sub.2 groups,R.sup.2 means a hydrogen atom or a hydroxyl group.The invention also covers a process for selective blocking the opioid binding sites of the brain responsible for respiratory depression by administering to a patient in need of an analgetic a preparation containing a codeinone derivative of general formula (I) or its salt preferably three times per day in doses of 2,5-5 mg.
    Type: Grant
    Filed: October 2, 1992
    Date of Patent: May 31, 1994
    Assignee: Alkaloida Chemical Company Ltd.
    Inventors: Anna Borsodi, Zsuzsa Furst, Sandor Hosztafi, Schafferne E. Varga, BuzaBeata, Tamas Friedmann, Sandor Benyhe, Maria Szucs